Bausch Health Companies Inc. (BHC)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$5.71
+2.33%
Mkt Cap $2.14B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 18, 2026 | $2.73B | $2.79B | +2.12% | $1.21 | $1.08 | -10.74% | — | — |
| Q4 2025 Oct 29, 2025 | $2.71B | $2.68B | -1.05% | $1.07 | $1.16 | +8.41% | — | — |
| Q3 2025 Jul 30, 2025 | $2.58B | $2.53B | -2.07% | $0.97 | $0.90 | -7.22% | — | — |
| Q2 2025 Apr 30, 2025 | $2.48B | $2.26B | -8.88% | $0.83 | $0.59 | -28.92% | — | — |
| Q1 2025 Feb 19, 2025 | $2.29B | $2.56B | +11.88% | $1.65 | $1.15 | -30.30% | — | — |
| Q4 2024 Oct 30, 2024 | $2.52B | $2.51B | -0.34% | $1.03 | $1.12 | +8.74% | — | — |
| Q3 2024 Aug 1, 2024 | $2.34B | $2.40B | +2.71% | $0.88 | $0.89 | +1.14% | — | — |
| Q2 2024 May 2, 2024 | $2.34B | $2.15B | -7.97% | $0.75 | $0.59 | -21.33% | — | — |
| Q1 2024 Feb 22, 2024 | $2.30B | $2.41B | +4.79% | $1.01 | $1.15 | +13.86% | — | — |
| Q4 2023 Nov 2, 2023 | $2.15B | $2.24B | +4.24% | $0.92 | $1.03 | +11.96% | — | — |
| Q3 2023 Aug 3, 2023 | $2.04B | $2.17B | +6.23% | $0.75 | $0.81 | +8.00% | — | — |
| Q2 2023 May 4, 2023 | $1.97B | $1.94B | -1.11% | $0.75 | $0.52 | -30.67% | — | — |
| Q1 2023 Feb 23, 2023 | $2.14B | $2.19B | +2.69% | $0.92 | $1.02 | +10.87% | — | — |
| Q4 2022 Nov 3, 2022 | $1.99B | $2.05B | +2.61% | $0.92 | $0.76 | -17.39% | — | — |
| Q3 2022 Aug 9, 2022 | $2.04B | $1.97B | -3.78% | $0.89 | $0.55 | -38.20% | — | — |
| Q2 2022 May 10, 2022 | $2.08B | $1.92B | -7.82% | $1.03 | $0.72 | -30.10% | — | — |
| Q1 2022 Feb 23, 2022 | $2.19B | $2.20B | +0.24% | $1.08 | $1.27 | +17.59% | — | — |
| Q4 2021 Nov 2, 2021 | $2.15B | $2.11B | -1.97% | $1.07 | $1.14 | +6.54% | — | — |
| Q3 2021 Aug 3, 2021 | $2.12B | $2.10B | -0.77% | $0.97 | $0.98 | +1.03% | — | — |
| Q2 2021 May 4, 2021 | $2.08B | $2.03B | -2.32% | $0.94 | $1.04 | +10.64% | — | — |